Diclofenac potassium + Ibuprofen + Placebo to ibuprofen + Placebo to diclofenac potassium
Phase 3Completed 0 watching 0 views this week📈 Rising
77
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Post Operative Dental Pain
Conditions
Post Operative Dental Pain
Trial Timeline
Apr 1, 2015 → Aug 1, 2015
NCT ID
NCT02476422About Diclofenac potassium + Ibuprofen + Placebo to ibuprofen + Placebo to diclofenac potassium
Diclofenac potassium + Ibuprofen + Placebo to ibuprofen + Placebo to diclofenac potassium is a phase 3 stage product being developed by Novartis for Post Operative Dental Pain. The current trial status is completed. This product is registered under clinical trial identifier NCT02476422. Target conditions include Post Operative Dental Pain.
Hype Score Breakdown
Clinical
27
Activity
18
Company
10
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02476422 | Phase 3 | Completed |
Competing Products
20 competing products in Post Operative Dental Pain